Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems
Nanomaterials · 31.07.2023 · 13 (15) · 2225
DOI: 10.3390/nano13152225 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 31.07.2023. Verfasst von Wan Su Yun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Korea Institute of Science and Technology (KU-KIST), Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of…. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea.
Abstract (Originalsprache)
Over the last 30 years, diverse types of nano-sized drug delivery systems (nanoDDSs) have been intensively explored for cancer therapy, exploiting their passive tumor targetability with an enhanced permeability and retention effect. However, their systemic administration has aroused some unavoidable complications, including insufficient tumor-targeting efficiency, side effects due to their undesirable biodistribution, and carrier-associated toxicity. In this review, the recent studies and advancements in intratumoral nanoDDS administration are generally summarized. After identifying the factors to be considered to enhance the therapeutic efficacy of intratumoral nanoDDS administration, the experimental results on the application of intratumoral nanoDDS administration to various types of cancer therapies are discussed. Subsequently, the reports on clinical studies of intratumoral nanoDDS administration are addressed in short. Intratumoral nanoDDS administration is proven with its versatility to enhance the tumor-specific accumulation and retention of therapeutic agents for various therapeutic modalities. Specifically, it can improve the efficacy of therapeutic agents with poor bioavailability by increasing their intratumoral concentration, while minimizing the side effect of highly toxic agents by restricting their delivery to normal tissues. Intratumoral administration of nanoDDS is considered to expand its application area due to its potent ability to improve therapeutic effects and relieve the systemic toxicities of nanoDDSs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Korea Institute of Science and Technology (KU-KIST), Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Republic of Korea.
- College of Pharmacy, Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Republic of Korea.
ORCID-Profile: Dong-Hwee Kim, Kwangmeyung Kim
Förderung
- National Research Foundation of Korea
Zitieren
APA
Yun, W. S., Kim, J., Lim, D. K., Kim, D. H., Jeon, S. I., & Kim, K. (2023). Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems. Nanomaterials, 13(15), 2225. https://doi.org/10.3390/nano13152225
Vancouver
Yun WS, Kim J, Lim DK, Kim DH, Jeon SI, Kim K. Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems. Nanomaterials. 2023;13(15):2225. doi:10.3390/nano13152225
BibTeX
@article{Yun2023,
author = {Yun, Wan Su and Kim, Jeongrae and Lim, Dong-Kwon and Kim, Dong-Hwee and Jeon, Seong Ik and Kim, Kwangmeyung},
title = {Recent Studies and Progress in the Intratumoral Administration of Nano-Sized Drug Delivery Systems},
journal = {Nanomaterials},
year = {2023},
volume = {13},
number = {15},
pages = {2225},
doi = {10.3390/nano13152225}
}
EUVIMED